AstraZeneca PLC Files July 2025 6-K Report
Ticker: AZN · Form: 6-K · Filed: Jul 1, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
Related Tickers: AZN
TL;DR
AZN filed its July 6-K, standard foreign issuer report.
AI Summary
AstraZeneca PLC filed a Form 6-K on July 1, 2025, reporting for the month of July 2025. The filing indicates that AstraZeneca is a foreign issuer and files annual reports under Form 20-F. The company's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Why It Matters
This filing serves as an update for investors and regulatory bodies regarding AstraZeneca's ongoing reporting obligations as a foreign issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not contain new material financial or operational information.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report
- 001-11960 (company) — Commission File Number
- 1 Francis Crick Avenue (company) — Company business address
- Cambridge Biomedical Campus (company) — Company business address
- CB2 0AA (company) — Company business address postal code
- United Kingdom (company) — Company country of operation
FAQ
What type of report is AstraZeneca PLC filing?
AstraZeneca PLC is filing a Form 6-K, which is a Report of Foreign Issuer.
For what period is this Form 6-K reporting?
This Form 6-K is reporting for the month of July 2025.
What is AstraZeneca PLC's Commission File Number?
AstraZeneca PLC's Commission File Number is 001-11960.
Does AstraZeneca PLC file annual reports under Form 20-F or 40-F?
The filing indicates that AstraZeneca PLC files annual reports under cover of Form 20-F.
Where are AstraZeneca PLC's principal executive offices located?
AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 1, 2025 regarding ASTRAZENECA PLC (AZN).